Menu Back toSP1

14th DIA Japan Annual Meeting 2017

[DIAmond Session 1] Vision of Future Drug Development in Utilizing Next-Generation Medical ICT

    Session Chair(s)
      Yasuhiro  Fujiwara, MD, PhD

      Yasuhiro Fujiwara, MD, PhD

      • Director General, Strategic Planning Bureau
      • National Cancer Center, Japan
      Yoshihiko  Ono, RPh

      Yoshihiko Ono, RPh

      • Executive Director, Head of Regulatory Affairs, Japan Development
      • MSD K.K., Japan
    Recently, under the Healthcare Policy, discussions are ongoing for Next-Generation Medical ICT on aiming to build and to utilize digital infrastructure in the areas of medical, nursing care, and health care. In this session, we will hold a panel discussion to offer respective views from industrial, academic, and government perspectives on the future direction of Next-Generation Medical ICT, and vision of future Drug Development including utilization or potential impact of ICT on clinical studies or on review for drug approval.
      Kouji  Fujimoto

      Policy and its Aim of Next-Generation Medical Information and Communication Technology (ICT)

      Kouji Fujimoto

      • Deputy Director-General, Office of Health and Medical Policy
      • Cabinet Secretariat, Japan
      Kazuhiko  Mori, MSc

      Vision of Future Drug Development in Utilizing Next-Generation Medical ICT

      Kazuhiko Mori, MSc

      • Councilor for Pharmaceutical Affairs, Minister’s Secretariat
      • Ministry of Health, Labour and Welfare (MHLW), Japan
      Tatsuya  Kondo, MD, PhD

      Drug Development Utilized Next Generation ICT - PMDA’s Efforts -

      Tatsuya Kondo, MD, PhD

      • Chief Executive
      • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
      Tomohiro  Sawa, MD, PhD

      Tomohiro Sawa, MD, PhD

      • Professor, Medical Information Systems Research Center
      • Teikyo University Hospital, Japan

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313